Table 1 Patient characteristics
Parameters | Overall population (n = 72) |
|---|---|
Age (years), median (IQR) | 66 (60–69) |
PSA (ng/mL), median (IQR) | 9.03 (5.95–13.36) |
Free PSA/PSA (%), median (IQR) | 12.76 (9.38–17.39) |
PSA density (ng/mL), median (IQR) | 0.26 (0.16–0.37) |
%p2PSA, median (IQR) | 2.04 (1.4–2.5) |
PHI, median (IQR) | 54.97 (42.41–78.04) |
PI-RADS score, n (%) | |
 2 | 4 (5.6) |
 3 | 3 (4.2) |
 4 | 29 (40.3) |
 5 | 36 (50) |
Radiological tumor diameter (cm), mean ± SD (95% CI) | 1.6 ± 0.89 (1.39–1.81) |
Biopsy cores, median (IQR) | |
 Targeted biopsy + systematic biopsy | 4 (2–8) + 15 (12–18) |
 Systematic biopsy alone | 14 (12–16) |
Biopsy grade group, n (%) | |
 1 | 25 (34.7) |
 2 | 19 (26.4) |
 3 | 13 (18.1) |
 4 | 12 (16.7) |
 5 | 3 (4.2) |
Histology grade group, n (%) | |
 1 | 10 (13.89) |
 2 | 28 (38.89) |
 3 | 28 (38.89) |
 4 | 1 (1.39) |
 5 | 5 (6.94) |
Histology T stage, n (%) | |
 2 | 52 (72.2) |
 3a | 16 (22.2) |
 3b | 3 (4.2) |
 4 | 1 (1.4) |
Histological tumor diameter (cm), mean ± SD (95% CI) | 2.13 ± 1.11 (1.86–2.39) |
Discrepancy between histological and radiological tumor diameter (cm), mean ± SD (95% CI) | 0.53 ± 0.67 (0.37–0.68) |